Literature DB >> 33001361

Esophagitis dissecans superficialis (EDS) secondary to esophagogastric junction outflow obstruction (EGJOO): a case report and literature review.

Tanya J Olszewski1, Shahin Ayazi1, Katrin Schwameis1, Stacey B Miller2, Kirsten Newhams1, Blair A Jobe3.   

Abstract

Esophageal dissecans superficialis (EDS) is a rare disease with endoscopic findings of sloughing squamous tissue with underlying normal mucosa and had no known cause. The literature does support possible causality between the presence of an esophageal stricture and EDS however there has been no association to date between EDS and esophagogastric junction outflow obstruction (EGJOO). We present a case of newly diagnosed EGJOO in a patient with long standing gastroesophageal reflux disease who presented with dysphagia. Evaluation identified endoscopically normal mucosa and a diagnosis of esophagogastric junction outflow obstruction on high resolution impedance manometry. A month later, repeat endoscopy identified diffusely sloughing mucosa consistent with EDS. Endoscopic dilation followed by a robotic Heller myotomy with Dor fundoplication to relive the outflow obstruction resulted in resolution of EDS in this case.

Entities:  

Keywords:  Dysphagia; Esophageal dissecans superficialis (EDS); Esophagogastric junction outflow obstruction (EGJOO); Gastroesophageal reflux disease (GERD); High resolution impedance manometry (HRIM)

Mesh:

Year:  2020        PMID: 33001361     DOI: 10.1007/s12328-020-01247-9

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  2 in total

1.  Higher Edmonton Obesity Staging System scores are associated with complications following laparoscopic Roux-en-Y gastric bypass.

Authors:  Samuel L Skulsky; Jerry T Dang; Adrian Battiston; Noah J Switzer; Daniel W Birch; Arya M Sharma; Shahzeer Karmali
Journal:  Surg Endosc       Date:  2019-08-27       Impact factor: 4.584

2.  The Clinical Course and Management of Severe Esophagitis Dissecans Superficialis: A Case Report.

Authors:  Isaac Jaben; Richard Schatz; Ira Willner
Journal:  J Investig Med High Impact Case Rep       Date:  2019 Jan-Dec
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.